These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 15553049

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
    Takemori N, Kondo K, Kawamura T, Imai K, Sakurai H, Sato T.
    Am J Hematol; 2001 Jan; 66(1):62-3. PubMed ID: 11426497
    [Abstract] [Full Text] [Related]

  • 5. Thalidomide for the treatment of leptomeningeal multiple myeloma.
    Yutaka H, Mariko Y, Shinichiro O, Kunihiko M, Yusuke T, Yasuo I.
    Eur J Haematol; 2006 Apr; 76(4):358-9. PubMed ID: 16519710
    [No Abstract] [Full Text] [Related]

  • 6. [New protocols for myeloma chemotherapy plus IFN alpha].
    Kitani T.
    Rinsho Ketsueki; 1993 Apr; 34(4):455-9. PubMed ID: 8510333
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of multiple myeloma--associated amyloidosis by interferon-alpha, dimethyl sulfoxide, and VAD (vincristine, adriamycin, and dexamethasone).
    Ichida M, Imagawa S, Ohmine K, Komatsu N, Hatake K, Ozawa K, Miura Y.
    Int J Hematol; 2000 Dec; 72(4):491-3. PubMed ID: 11197218
    [Abstract] [Full Text] [Related]

  • 8. [New treatment strategies for multiple myeloma].
    Ozaki S.
    Rinsho Ketsueki; 2009 Oct; 50(10):1506-17. PubMed ID: 19915360
    [No Abstract] [Full Text] [Related]

  • 9. [Multiple myeloma complicated with Takotsubo cardiomyopathy].
    Mitsumori T, Nakajima K, Nozaki Y, Hamanaka S, Nagashima T, Kirito K, Iwao N, Komatsu N.
    Rinsho Ketsueki; 2010 Apr; 51(4):291-6. PubMed ID: 20467228
    [Abstract] [Full Text] [Related]

  • 10. [Granulocyte-colony stimulating factor-producing myeloma with clinical manifestations mimicking chronic neutrophilic leukemia].
    Kusaba N, Yoshida H, Ohkubo F, Mishima K, Shimamastu K, Okamura T, Sata M.
    Rinsho Ketsueki; 2004 Mar; 45(3):228-32. PubMed ID: 15103937
    [Abstract] [Full Text] [Related]

  • 11. [IgM-lambda multiple myeloma presenting with systemic amyloidosis].
    Higeta D, Yokohama A, Osaki Y, Tahara K, Mawatari M, Sekigami T, Koiso H, Saito T, Uchiumi H, Handa H, Karasawa M, Murakami H, Hirato J, Tsukamoto N, Nojima Y.
    Rinsho Ketsueki; 2009 Dec; 50(12):1711-4. PubMed ID: 20068279
    [Abstract] [Full Text] [Related]

  • 12. Multiple myeloma with multiple and bulky extramedullary plasmacytomas as initial presentation.
    SAWADA T, NAJIMA Y, OHASHI K, KATO I, MIYAZAWA M, NAKANO M, KOBAYASHI T, YAMASHITA T, AKIYAMA H, SAKAMAKI H.
    Rinsho Ketsueki; 2009 Nov; 50(11):1635-40. PubMed ID: 20009440
    [Abstract] [Full Text] [Related]

  • 13. Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.
    Vogl DT, Liu SV, Chong EA, Luger SM, Porter DL, Schuster SJ, Tsai DE, Perl A, Loren AW, Goldstein SC, Nasta SD, Andreadis C, Mangan PA, Hummel K, Siegel DL, Glatstein E, Stadtmauer EA.
    Am J Hematol; 2007 Dec; 82(12):1071-5. PubMed ID: 17696204
    [Abstract] [Full Text] [Related]

  • 14. [A case of aggressive multiple myeloma].
    Oda Y, Ooi S, Endoh A, Urushidani Y, Nakamura R, Adachi K.
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):489-92. PubMed ID: 21403462
    [Abstract] [Full Text] [Related]

  • 15. [Gross spreading multiple extramedullary plasmacytomas to the skin in the terminal stage of multiple myeloma].
    Kanno M, Nakamura S, Danno D, Uotani C, Kotani T, Yamanaka S, Terasaki Y, Matano S, Okumura H.
    Rinsho Ketsueki; 2001 Jul; 42(7):554-8. PubMed ID: 11524846
    [Abstract] [Full Text] [Related]

  • 16. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
    Kaya H, Nakamura S, Yamazaki H, Kumabashiri I, Ohtake S, Matsuda T.
    Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597
    [Abstract] [Full Text] [Related]

  • 17. [Effective combination therapy of bortezomib and dexamethasone for two patients with refractory multiple myeloma].
    Ikeda H, Hayashi T, Nojima M, Yasui H, Ikeda Y, Ishida T, Adachi M, Imai K.
    Rinsho Ketsueki; 2005 Apr; 46(4):269-73. PubMed ID: 16444959
    [Abstract] [Full Text] [Related]

  • 18. Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.
    Mellqvist UH, Lenhoff S, Johnsen HE, Hjorth M, Holmberg E, Juliusson G, Tangen JM, Westin J, Nordic Myeloma Study Group.
    Cancer; 2008 Jan 01; 112(1):129-35. PubMed ID: 17973267
    [Abstract] [Full Text] [Related]

  • 19. Vincristine, doxorubicin, and dexamethasone or thalidomide plus dexamethasone for newly diagnosed patients with multiple myeloma?
    Jimenez-Zepeda VH, Domínguez-Martínez VJ.
    Eur J Haematol; 2006 Sep 01; 77(3):239-44. PubMed ID: 16856924
    [Abstract] [Full Text] [Related]

  • 20. [The successful use of natural alpha-interferon single therapy in multiple myeloma of IgD (lambda)-type].
    Suzuki A, Iwase O, Ohkubo T, Nakano M, Toyama K.
    Rinsho Ketsueki; 1991 Jan 01; 32(1):47-51. PubMed ID: 1902271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.